Loading stock data…
$76.25-0.07 (-0.09%)
Globus Medical, Inc.
Globus Medical, Inc. in the Healthcare sector is trading at $76.14 with a market capitalization of $11.5B. Wall Street consensus targets $100.92 (13 analysts), implying a +32.5% move over the next 12 months. The stock is currently 25% below its 52-week high of $101.40, remaining 9.5% below its 200-day moving average. On fundamentals, Piotroski 9/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $789.61M↑ | $759.85M↓ | $826.42M↑ | $769.05M↑ | $745.34M |
| Gross Profit | $548.17M↑ | $525.79M↓ | $565.31M↑ | $516.51M↑ | $496.58M |
| Operating Income | $195.47M↑ | $161.98M↓ | $181.31M↑ | $135.01M↑ | $122.81M |
| Net Income | $151.57M↑ | $124.30M↓ | $140.59M↑ | $118.97M↓ | $202.85M |
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle scre...